A small step towards being a normal companyToday’s news does not trigger a spike in price, probably the 3000 patients is not a significant figure considered by the market. Or probably news is not coming in close sequence enough to create a hype. Nevertheless it is worth to take note the company is ready to feed us with better and better new development. And it is inspiring. Stock will still run on technicals by traders working with the trading range under 0.45, most likely until the Q2 in March when fundamentals will take over like a normal company is treated. This has been mentioned in my older posts. The key to become a normal company is the proof of established steady revenue stream over time. The executive summary on company webpage laid out the plan based on the available data at the time of writing. Any new developments like today’s are additions and reinforcement to the plan.
At this point my stand as reflects on my post ”Buy, Sell or Hold” does not change. Still holding, still play the volatility to my advantage to lower investment cost and still making money while waiting.